ZetrOZ Systems

Executive Summary

ZetrOZ Systems is a privately held medical device company headquartered in Trumbull, CT, and recognized as a global leader in non-invasive therapeutic ultrasound technology. Founded in 2010, the company develops and manufactures devices that accelerate tissue healing and provide pain relief for chronic musculoskeletal conditions. Its core technology leverages low-intensity pulsed ultrasound (LIPUS) to stimulate cellular repair processes, offering a safe, drug-free alternative to surgery or pharmaceuticals. ZetrOZ’s flagship product, the sam® (Sustained Acoustic Medicine) wearable system, is FDA-cleared and reimbursed by major insurers, with clinical evidence supporting efficacy in conditions such as osteoarthritis, tendinitis, and lower back pain. The company’s patient-focused, clinically validated approach positions it as a key player in the growing non-invasive pain management market. Looking ahead, ZetrOZ Systems is poised for expansion through product line extensions and geographic market penetration. The company is expected to pursue additional FDA clearances for new indications and next-generation wearable devices, capitalizing on the shift toward home-based care and value-based reimbursement models. Strategic partnerships with orthopedic practices, sports medicine clinics, and physical therapy networks could further drive adoption. With a strong intellectual property portfolio and a proven commercial track record, ZetrOZ is well-positioned to capture a larger share of the multi-billion-dollar pain relief market. However, competition from other ultrasound-based and neuromodulation devices remains a risk. Overall, the company’s established clinical credibility and regulatory wins support a favorable outlook.

Upcoming Catalysts (preview)

• Q2 2026FDA 510(k) Clearance for Next-Generation Wearable Ultrasound Device80% success
• Q4 2025Publication of Pivotal Clinical Study Results in Peer-Reviewed Journal70% success
• H1 2026Strategic Partnership with Major Orthopedic Group or Insurance Provider60% success